Lumbosacral Plexus Neurolymphomatosis: A Typical 18FDG PET/CT Pattern to Recognize.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
01 Apr 2022
Historique:
pubmed: 6 11 2021
medline: 5 3 2022
entrez: 5 11 2021
Statut: ppublish

Résumé

A 79-year-old man anteriorly treated for primary central nervous system diffuse large B-cell lymphoma with MRI complete response after immunochemotherapy was referred 1 year later for 18FDG PET/CT because of right persistent lombosciatic radicular pain for 6 months with negative medullary and spine MRI and negative cerebrospinal fluid cytology. Linearly intense uptake was observed in several roots of lumbosacral plexus, highly suggestive of peripheral neurolymphomatosis relapse. No specific treatment was engaged because of rapid decrease of performance status leading to death.

Identifiants

pubmed: 34739401
doi: 10.1097/RLU.0000000000003949
pii: 00003072-202204000-00019
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-353

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: none declared.

Références

Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood . 2010;115:5005–5011.
Chamberlain MC, Fink J. Neurolymphomatosis: a rare metastatic complication of diffuse large B-cell lymphoma. J Neurooncol . 2009;95:285–288.
Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J . 2012;18:463–468.
DeVries AH, Howe BM, Spinner RJ, et al. B-cell peripheral neurolymphomatosis: MRI and 18 F-FDG PET/CT imaging characteristics. Skeletal Radiol . 2019;48:1043–1050.
Salm LP, Van der Hiel B, Stokkel MP. Increasing importance of 18 F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun . 2012;33:907–916.
Ganeshalingam R, Roach P, Schembri GP. Diffuse large B-cell lymphoma recurring as neurolymphomatosis on FDG PET/CT. Clin Nucl Med . 2019;44:145–147.
Canh NX, Tan NV, Tung TT, et al. 18 F-FDG PET/CT in neurolymphomatosis: report of 3 cases. Asia Ocean J Nucl Med Biol . 2014;2:57–64.
Davidson T, Kedmi M, Avigdor A, et al. FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Leuk Lymphoma . 2018;59:348–356.
Pan Q, Luo Y. Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18 F-FDG PET/CT: a case report and literature review. Medicine (Baltimore) . 2020;99:e18640.

Auteurs

Karl Bordeau (K)

From the Departments of Nuclear Medicine.

Marie-Claude Eberlé (MC)

From the Departments of Nuclear Medicine.

Michel Fabbro (M)

Medical Oncology, Institut Régional du Cancer de Montpellier, Université de Montpellier.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH